Previous 10 | Next 10 |
KANSAS CITY, Mo., April 28, 2020 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2020 first quarter that ended March 31, 2020. Bookings in the first quarter of 2020 were $1.09 billion, at the low end of the Company’s expectations as the ou...
Cerner (NASDAQ: CERN ) is scheduled to announce Q1 earnings results on Tuesday, April 28th, after market close. The consensus EPS Estimate is $0.70 (+14.8% Y/Y) and the consensus Revenue Estimate is $1.43B (+2.9% Y/Y). Over the last 2 years, CERN has beaten EPS estimates 50% of the t...
KANSAS CITY, Mo., April 24, 2020 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN), a global health care technology company, is now offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight th...
Citing Cerner's (NASDAQ: CERN ) strong positioning amid the coronavirus pandemic, Jefferies analyst David Windley upgrades the company from Hold to Buy and increases the price target from $75 to $90, a 31% upside. More news on: Cerner Corporation, Tech stocks news, Stocks on the move,...
Cerner ( CERN ) is one of the relatively safer stocks in the market today, despite the short-term COVID-19 headwinds. Investors also seem to have realized the resilience in this company, as evidenced by share price movement in the last few weeks. The stock had crashed from $73.40 on January 2 ...
New York City, NY: April 16, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of e-Prescription Systems Market in Global Industry: 2020 Research and New Innovations in Technology and Media Sector. The prime objective of the report is to offer upd...
KANSAS CITY, Mo., April 15, 2020 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its first quarter 2020 earnings results after the market closes Tuesday, April 28 th . Following the release, the company will hold a conference call at 3:30 p.m. CT th...
New York City, NY: April 14, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Blood Bank Information System Market in Global Industry: 2020 Research and New Innovations in Technology and Media Sector. The prime objective of the report is to of...
Allogene Therapeutics (NASDAQ: ALLO ) initiated with Buy rating and $29 (28% upside) price target at SunTrust. More news on: Allogene Therapeutics, Inc., BridgeBio Pharma, Inc., Cerner Corporation, Healthcare stocks news, Stocks on the move, , Read more ...
KANSAS CITY, Mo., March 30, 2020 (GLOBE NEWSWIRE) -- Today, Cerner Corporation (Nasdaq: CERN), a global health care technology company, is recognizing National Doctors’ Day, an opportunity to thank physicians for their contributions to the health of communities throughout th...
News, Short Squeeze, Breakout and More Instantly...
Nova Scotia and Oracle Cerner Begin a New Era in Healthcare Canada NewsWire New 10-year agreement to provide more efficient, secure, timely access to patient information HALIFAX, NS , Feb. 1, 2023 /CNW/ -- The province of Nova Scotia , in collabo...
Oracle Completes Acquisition of Cerner PR Newswire AUSTIN, Texas , June 7, 2022 /PRNewswire/ -- Oracle Corporation (NYSE: ORCL) announced that a majority of the outstanding shares (the "Shares") of Cerner Corporation (Nasdaq: CERN) were validly tende...
Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600 Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600...